Hotaling Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Hotaling Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$3.29M	Buy	45,763 +26,399	+136%	+$1.99M	1.49%	21
2022 Q3	$1.38M	Sell	19,364 -64	-0.3%	-$4.64K	0.66%	50
2022 Q2	$1.5M	Buy	19,428 +64	+0.3%	+$4.87K	0.65%	52
2022 Q1	$1.41M	Hold	19,364	–	–	0.54%	54
2021 Q4	$1.21M	Buy	19,364 +2,400	+14%	+$141K	0.42%	66
2021 Q3	$1M	Sell	16,964 -147	-0.9%	-$9.68K	0.42%	69
2021 Q2	$1.14M	Hold	17,111	–	–	0.46%	68
2021 Q1	$1.08M	Buy	17,111 +280	+2%	+$17.4K	0.48%	64
2020 Q4	$1.04M	Hold	16,831	–	–	0.49%	62
2020 Q3	$1.01M	Sell	16,831 -1,270	-7%	-$76.4K	0.55%	59
2020 Q2	$1.06M	Buy	18,101 +1,080	+6%	+$64.6K	0.61%	57
2020 Q1	$949K	Hold	17,021	–	–	0.71%	48
2019 Q4	$1.09M	Hold	17,021	–	–	0.63%	58
2019 Q3	$863K	Hold	17,021	–	–	0.55%	60
2019 Q2	$772K	Sell	17,021 -133	-0.8%	-$6.2K	0.5%	69
2019 Q1	$818K	Hold	17,154	–	–	0.55%	64
2018 Q4	$892K	Buy	+17,154	New	+$922K	0.73%	53

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Hotaling Investment Management's BMY Position: Q4 2022 in Review

Hotaling Investment Management increased its Bristol-Myers Squibb (BMY) stake by 136% in Q4 2022, buying an estimated $1.99M and bringing the position to 45,763 shares worth $3.29M. The position accounts for 1.49% of the portfolio, ranked #21.

Hotaling Investment Management first reported a position in BMY in Q4 2018 and has held it in 17 quarters since. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

Hotaling Investment Management held 45,763 shares of Bristol-Myers Squibb worth $3.29M as of Q4 2022.
Hotaling Investment Management bought 26,399 Bristol-Myers Squibb shares in Q4 2022, an estimated $1.99M.
Bristol-Myers Squibb made up 1.49% of Hotaling Investment Management's portfolio in Q4 2022, its #21 holding.
Hotaling Investment Management first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 17 quarters since.
2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Hotaling Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.